Trial Profile
Gastrointestinal Behavior of Posaconazole in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2019
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses; Oropharyngeal candidiasis
- Focus Pharmacokinetics
- 12 Aug 2019 Status changed from recruiting to completed.
- 19 Jul 2016 New trial record